• Home
  • News

Zoetis Announces Appointment of Roman Trawicki as President of Global Manufacturing and Supply

Trawicki joins Zoetis from GE Healthcare and brings more than 20 years of experience in healthcare manufacturing and operations to the role

Monday, November 24, 2014 9:00 am EST

Dateline:

FLORHAM PARK, N.J.

Public Company Information:

NYSE:
ZTS
"Forward-Looking Information and Factors That May Affect Future Results"

FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced the appointment of Roman Trawicki as President of its Global Manufacturing and Supply organization.

With more than 20 years of broad, international experience in healthcare manufacturing and operations, Mr. Trawicki will oversee the company’s global manufacturing and supply network that produces more than 300 animal health product lines for the company. As the world leader in animal health, Zoetis utilizes a network of 27 internal manufacturing facilities and about 200 external suppliers to manufacture and deliver its products to veterinarians and livestock producers in more than 120 countries.

Mr. Trawicki will join Zoetis from GE Healthcare, where he has been General Manager of Global Supply Chain for Medical Diagnostics focusing on diagnostics, injectable contrast media and nuclear medicines. In that role, he has managed 2,500 colleagues across the world and overseen 16 manufacturing sites. During his career he has gained extensive global leadership experience in lean manufacturing, supply and operations from additional roles at GE Healthcare, Coloplast and Smith & Nephew.

“I am confident that Zoetis will benefit from Roman’s experience and leadership, along with his manufacturing, operations, and continuous improvement expertise,” said Kristin Peck, Executive Vice President and Group President for Zoetis, with responsibility for manufacturing and supply. “He brings an outside perspective that will strengthen our manufacturing organization and serve us well as we capitalize on advances inside and outside of Zoetis to optimize our network for the future. As always, our collective goal remains to deliver high quality, reliable supply at competitive costs, and drive profitable results for Zoetis.”

Mr. Trawicki earned his bachelor’s degree in Mechanical Engineering from University of Hertfordshire, U.K. in 1986, and worked in engineering roles for Ford Motor Company, Black & Decker Corporation and Cummins Engine Company before moving into the healthcare sector at Smith & Nephew in 1992.

Mr. Trawicki will join the company on January 1, 2015, replacing Carolyn Hawver, current president of the Global Manufacturing and Supply organization. Ms. Hawver had announced her retirement plans earlier in the year, and the appointment of Mr. Trawicki completes that leadership transition. He will be based at the company’s location in Zaventem, Belgium, and report to Ms. Peck.

About Zoetis

Zoetis (zô-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. In 2013, the company generated annual revenue of $4.6 billion. With approximately 9,800 employees worldwide at the beginning of 2014, Zoetis has a local presence in approximately 70 countries, including 27 manufacturing facilities in 10 countries. Its products serve veterinarians, livestock producers and people who raise and care for farm and companion animals in 120 countries. For more information, visit www.zoetis.com.

DISCLOSURE NOTICES

Forward-Looking Statements: This press release contains forward-looking statements, which reflect the current views of Zoetis with respect to business plans or prospects, future operating or financial performance, expectations regarding products, future use of cash and dividend payments, and other future events. These statements are not guarantees of future performance or actions. Forward-looking statements are subject to risks and uncertainties. If one or more of these risks or uncertainties materialize, or if management's underlying assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Forward-looking statements speak only as of the date on which they are made. Zoetis expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. A further list and description of risks, uncertainties and other matters can be found in our Annual Report on Form 10-K for the fiscal year ended December 31, 2013, including in the sections thereof captioned “Forward-Looking Information and Factors That May Affect Future Results” and “Item 1A. Risk Factors,” in our Quarterly Reports on Form 10-Q and in our Current Reports on Form 8-K. These filings and subsequent filings are available online at www.sec.gov, www.zoetis.com, or on request from Zoetis.

Contact:

Media Contacts:
Bill Price, 1-973-443-2742 (o)
william.price@zoetis.com
or
Elinore White, 1-973-443-2835 (o)
elinore.y.white@zoetis.com
or
Investor Contact:
John O'Connor, 1-973-822-7088 (o)
john.oconnor@zoetis.com